WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
2026 JPM: FIC/BIC pipeline breakthrough, BD harvest, Hong Kong stock listing! Hengrui reaches the "tipping point"
Guosen: The global asset allocation logic is undergoing a shift; the macro narrative is transitioning from valuation repair to profit realization.
Guolian Minsheng Securities: Acceleration of equal rights for autonomous driving in 2025. In 2026, the resonance of autonomous driving, Siasun Robot & Automation, and globalization.
2026 JPM: FIC/BIC pipeline breakthrough, BD harvest, Hong Kong stock listing! Hengrui reaches the "tipping point"
Guosen: The global asset allocation logic is undergoing a shift; the macro narrative is transitioning from valuation repair to profit realization.
Guolian Minsheng Securities: Acceleration of equal rights for autonomous driving in 2025. In 2026, the resonance of autonomous driving, Siasun Robot & Automation, and globalization.
